Medelamines, Novel Anticancer Agents which
Cancel RAS2va119 Induced Heat Shock Sensitivity of Yeast Sir:
Missense mutations of ras oncogenes (K-ras, H-ras and N-ras) at the amino-terminus 12th amino acid are often found in colon and pancreas cancer. Compoundswhich suppress function of mutated ras oncogene products have been screened for a use in treatment of these cancers1}. Inhibitors of ras farnesyltransferase has also been screened since farnesylation of ras proteins is needed for normal localization and function of ras proteins2). Biochemical and molecular analysis of ras proteins have revealed structural and functional similarity between human and yeast, Saccharomyces cerevisiae3\
According to amino acid sequence alignment, since yeast ras2 protein had 7 redundant amino acids at the terminal region, a corresponding mutation was introduced to yeast ras2 gene at the amino-terminus 19th amino acid of the protein4). This mutaion ras2ya119, i.e. a missense mutation (glycine->valine) at the 19th amino acid induced abnormal signaling and caused the definite phenotypic changes, such as heat shock sensitivity of strain5). We report a screening system for compounds which cancel heat shock sensitivity of the yeast mutant strain and isolation of novel compounds, medelamine A and B. Wealso report their cytotoxicities and enzyme inhibitory activities against ras farnesyltransferase.
For the screeing system yeast strain carrying the ras2ya119 mutation was used4). Strain was inoculated with 30ml of YPDmedium (1% yeast extract, 2%
bacto-peptone, 2% glucose and 0.9% agar purified [Difco]) into a square plastic plate (10cmx 14cm).
Thick paper discs with 6mmdiameter were immersed with sample solutions and applied to the agar plate. For sample diffusion the plate was incubatd at 4°C
overnight. This plate was incubated at 30°C for 8 hours for primary cultivation. Then, heat shock was carried out by floating the plate on hot water (50°C) for 10 minutes. To detect survived strain after this treatment the plate was incubated further for 16hours at 30°C. Sample which gave growth zone around the disc was selected as a candidate which cancelled the heat shock sensitivity of yeast. Finally, an assay without heat shock treatment was done and a sample which did not promote yeast growth was selected. Anexample of this assay was shown in Fig. 1 . Microbial cultured broth were applied to the assay.
Among 4000 samples, one culture, Streptomyces sp.
NK14819strain, which was isolated from soil collected in Saitama Prefecture, Japan, was selected. The active compound was produced by rotary shaking culture in a (Fig. 2) . The N-PMZderivatives thus obtained were applied to preparative HPLCand detected with UV absorption at 254nm of PMZgroup (Fig. 3 ). The compound in Peak A and B were isolated and its PMZ group was removed in acidic condition (Fig. 2) . The Finally, PMZgroup was removed in acidic condition.
tablished as C14H31N (213) and C15H33N (227) respectively based on HRFAB-MSand *H and 13C NMR spectra. Structures of these compoundswere determined by means of chemical and spectrometric methods. Each medelamine has novel alkylamine structure (Fig. 4) . The nameof medelaminewas derived from the structure of 12-methyltridecylamine of A and 12-methyltetradecylamine of B. Structural determination and total synthesis of the medelamine will be described in detail elsewhere. The activity of medelamines to cancel the heat shock sensitivity of yeast was examined as demonstrated in Fig. 1 and summarized in Table 1 . Both medelamines showed nearly the same activity in this assay. Growth inhibitory activities of medelaminesagainst cultured cells were investigated with rat normal kidney cell line, NRK6) and its transformant cell line, K-NRK7). K-NRK cell had been constructed by introduction to NRKcell of v-H-ras gene which had a missense mutation at the amino-terminus 12th amino acid7). As shown in Table   2 , both medelamines showed growth inhibitory activites against both cells. There observed a tendancy that K-NRKcell was slightly more susceptible than NRK cell. However, several anticancer drugs such as 5-fluorouracil, pepleomycin, vincristine, cisplatin, adriamycin and etoposide showed diverse selectivities to KNRKcell, and some of them showed further selectivities than medelamines. Therefore, anti-ras activity of medelamines could not be concluded by the cytotoxicities. In elsewhere. order to investigate a possible mode of action, an inhibitory activity against ras farnesyltransferase was also examined. As shown in Table 2 both medelamines inhibited ras farnesylation reaction in cell free system. Therefore interruption of farnesylation of rasva1 1 9 protein maybe speculated as a possible action ofmedelamines in this assay. However their precise biological properties should be demonstrated in detail since medelamines also inhibited protein kinase C and A in our preliminary experiments. Medelamine A showed cytotoxicity and moderate acute toxicity in mice. Its anticancer activity in vivo is nowunder examination and will be reported AUG. 1995 
